KRAS and colorectal cancer: Given that KRASG12D is the most frequent KRAS mutation in both pancreatic and colorectal cancers, we further extended our analysis to include KRASG12D-mutant pancreatic (PANC-1) and colorectal (LS174T) cell lines.